back
| XLS Download |
|
Total revenues, sales, operating result (EBIT) and R&D costs, by division (€ million) |
|||||||||
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
||||
|
|
Biopharmaceuticals |
Consumer Health |
Performance Materials |
Life Science |
Group* |
||||
|
|||||||||
|
|
|
|
|
|
|
||||
|
2013** |
|
|
|
|
|
||||
|
Total revenues |
6,060.4 |
745.0 |
1,644.4 |
2,645.3 |
11,095.1 |
||||
|
Sales |
5,688.4 |
742.1 |
1,642.1 |
2,627.5 |
10,700.1 |
||||
|
Operating result (EBIT) |
793.1 |
162.1 |
653.3 |
262.0 |
1,610.8 |
||||
|
R&D costs |
1,178.1 |
21.8 |
145.4 |
159.8 |
1,506.6 |
||||
|
|
|
|
|
|
|
||||
|
2014 |
|
|
|
|
|
||||
|
Total revenues |
5,975 |
768.8 |
2,060.5 |
2,696.5 |
11,500.8 |
||||
|
Sales |
5,783.3 |
766.1 |
2,059.6 |
2,682.5 |
11,291.5 |
||||
|
Operating result (EBIT) |
956.5 |
149.9 |
611.5 |
289.2 |
1,762.0 |
||||
|
R&D costs |
1,343.7 |
22.3 |
170.6 |
162.6 |
1,703.7 |
||||
